A citation-based method for searching scientific literature

H Lahat, E Pras, T Olender, N Avidan, E Ben-Asher, O Man, E Levy-Nissenbaum, A Khoury, A Lorber, B Goldman, D Lancet, M Eldar. Am J Hum Genet 2001
Times Cited: 440







List of co-cited articles
2076 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia.
S G Priori, C Napolitano, N Tiso, M Memmi, G Vignati, R Bloise, V Sorrentino, G A Danieli. Circulation 2001
910
63

Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.
Silvia G Priori, Carlo Napolitano, Mirella Memmi, Barbara Colombi, Fabrizio Drago, Maurizio Gasparini, Luciano DeSimone, Fernando Coltorti, Raffaella Bloise, Roberto Keegan,[...]. Circulation 2002
729
49

Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients.
A Leenhardt, V Lucet, I Denjoy, F Grau, D D Ngoc, P Coumel. Circulation 1995
603
44

Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death.
Mette Nyegaard, Michael T Overgaard, Mads T Søndergaard, Marta Vranas, Elijah R Behr, Lasse L Hildebrandt, Jacob Lund, Paula L Hedley, A John Camm, Göran Wettrell,[...]. Am J Hum Genet 2012
219
43

Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia.
Meiso Hayashi, Isabelle Denjoy, Fabrice Extramiana, Alice Maltret, Nathalie Roux Buisson, Jean-Marc Lupoglazoff, Didier Klug, Miyuki Hayashi, Seiji Takatsuki, Elisabeth Villain,[...]. Circulation 2009
292
42

Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human.
Nathalie Roux-Buisson, Marine Cacheux, Anne Fourest-Lieuvin, Jeremy Fauconnier, Julie Brocard, Isabelle Denjoy, Philippe Durand, Pascale Guicheney, Florence Kyndt, Antoine Leenhardt,[...]. Hum Mol Genet 2012
154
41

HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013.
Silvia G Priori, Arthur A Wilde, Minoru Horie, Yongkeun Cho, Elijah R Behr, Charles Berul, Nico Blom, Josep Brugada, Chern-En Chiang, Heikki Huikuri,[...]. Heart Rhythm 2013
41


Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry.
Thomas M Roston, Jeffrey M Vinocur, Kathleen R Maginot, Saira Mohammed, Jack C Salerno, Susan P Etheridge, Mitchell Cohen, Robert M Hamilton, Andreas Pflaumer, Ronald J Kanter,[...]. Circ Arrhythm Electrophysiol 2015
124
31

Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia.
Christian van der Werf, Prince J Kannankeril, Frederic Sacher, Andrew D Krahn, Sami Viskin, Antoine Leenhardt, Wataru Shimizu, Naokata Sumitomo, Frank A Fish, Zahurul A Bhuiyan,[...]. J Am Coll Cardiol 2011
241
28

Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia.
P J Laitinen, K M Brown, K Piippo, H Swan, J M Devaney, B Brahmbhatt, E A Donarum, M Marino, N Tiso, M Viitasalo,[...]. Circulation 2001
500
28

Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans.
Hiroshi Watanabe, Nagesh Chopra, Derek Laver, Hyun Seok Hwang, Sean S Davies, Daniel E Roach, Henry J Duff, Dan M Roden, Arthur A M Wilde, Björn C Knollmann. Nat Med 2009
372
27

Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia.
Alex V Postma, Isabelle Denjoy, Theo M Hoorntje, Jean-Marc Lupoglazoff, Antoine Da Costa, Pascale Sebillon, Marcel M A M Mannens, Arthur A M Wilde, Pascale Guicheney. Circ Res 2002
285
27

Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation.
Gaetano M De Ferrari, Veronica Dusi, Carla Spazzolini, J Martijn Bos, Dominic J Abrams, Charles I Berul, Lia Crotti, Andrew M Davis, Michael Eldar, Maria Kharlap,[...]. Circulation 2015
143
25

Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia.
Björn C Knollmann, Nagesh Chopra, Thinn Hlaing, Brandy Akin, Tao Yang, Kristen Ettensohn, Barbara E C Knollmann, Kenneth D Horton, Neil J Weissman, Izabela Holinstat,[...]. J Clin Invest 2006
320
24

Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives.
Christian van der Werf, Ineke Nederend, Nynke Hofman, Nan van Geloven, Corné Ebink, Ingrid M E Frohn-Mulder, A Marco W Alings, Hans A Bosker, Frank A Bracke, Freek van den Heuvel,[...]. Circ Arrhythm Electrophysiol 2012
92
21

Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia.
Lei Song, Ronny Alcalai, Michael Arad, Cordula M Wolf, Okan Toka, David A Conner, Charles I Berul, Michael Eldar, Christine E Seidman, J G Seidman. J Clin Invest 2007
124
19

The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis.
Argelia Medeiros-Domingo, Zahurul A Bhuiyan, David J Tester, Nynke Hofman, Hennie Bikker, J Peter van Tintelen, Marcel M A M Mannens, Arthur A M Wilde, Michael J Ackerman. J Am Coll Cardiol 2009
198
18

Single delivery of an adeno-associated viral construct to transfer the CASQ2 gene to knock-in mice affected by catecholaminergic polymorphic ventricular tachycardia is able to cure the disease from birth to advanced age.
Marco Denegri, Rossana Bongianino, Francesco Lodola, Simona Boncompagni, Verónica C De Giusti, José E Avelino-Cruz, Nian Liu, Simone Persampieri, Antonio Curcio, Francesca Esposito,[...]. Circulation 2014
56
32


Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients.
A V Postma, I Denjoy, J Kamblock, M Alders, J-M Lupoglazoff, G Vaksmann, L Dubosq-Bidot, P Sebillon, M M A M Mannens, P Guicheney,[...]. J Med Genet 2005
183
17

Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death.
N Sumitomo, K Harada, M Nagashima, T Yasuda, Y Nakamura, Y Aragaki, A Saito, K Kurosaki, K Jouo, M Koujiro,[...]. Heart 2003
238
17

RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR).
Dawei Jiang, Bailong Xiao, Dongmei Yang, Ruiwu Wang, Philip Choi, Lin Zhang, Heping Cheng, S R Wayne Chen. Proc Natl Acad Sci U S A 2004
307
16


Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate.
Christina Y Miyake, Gregory Webster, Richard J Czosek, Michal J Kantoch, Anne M Dubin, Kishor Avasarala, Joseph Atallah. Circ Arrhythm Electrophysiol 2013
63
25

Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia.
Raymond W Sy, Michael H Gollob, George J Klein, Raymond Yee, Allan C Skanes, Lorne J Gula, Peter Leong-Sit, Robert M Gow, Martin S Green, David H Birnie,[...]. Heart Rhythm 2011
115
16

Efficacy of Flecainide in the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: A Randomized Clinical Trial.
Prince J Kannankeril, Jeremy P Moore, Marina Cerrone, Silvia G Priori, Naomi J Kertesz, Pamela S Ro, Anjan S Batra, Elizabeth S Kaufman, David L Fairbrother, Elizabeth V Saarel,[...]. JAMA Cardiol 2017
65
24

Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia.
Arthur A M Wilde, Zahurul A Bhuiyan, Lia Crotti, Mario Facchini, Gaetano M De Ferrari, Thomas Paul, Chiara Ferrandi, Dave R Koolbergen, Attilio Odero, Peter J Schwartz. N Engl J Med 2008
270
15

Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts.
H Swan, K Piippo, M Viitasalo, P Heikkilä, T Paavonen, K Kainulainen, J Kere, P Keto, K Kontula, L Toivonen. J Am Coll Cardiol 1999
220
15

A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia.
Belinda Gray, Richard D Bagnall, Lien Lam, Jodie Ingles, Christian Turner, Eric Haan, Andrew Davis, Pei-Chi Yang, Colleen E Clancy, Raymond W Sy,[...]. Heart Rhythm 2016
29
51

Calmodulin mutations associated with recurrent cardiac arrest in infants.
Lia Crotti, Christopher N Johnson, Elisabeth Graf, Gaetano M De Ferrari, Bettina F Cuneo, Marc Ovadia, John Papagiannis, Michael D Feldkamp, Subodh G Rathi, Jennifer D Kunic,[...]. Circulation 2013
213
14


Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism.
Igor Splawski, Katherine W Timothy, Leah M Sharpe, Niels Decher, Pradeep Kumar, Raffaella Bloise, Carlo Napolitano, Peter J Schwartz, Robert M Joseph, Karen Condouris,[...]. Cell 2004
983
14

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).
Michael J Ackerman, Silvia G Priori, Stephan Willems, Charles Berul, Ramon Brugada, Hugh Calkins, A John Camm, Patrick T Ellinor, Michael Gollob, Robert Hamilton,[...]. Heart Rhythm 2011
612
14

Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia.
Marina Raffaele di Barletta, Serge Viatchenko-Karpinski, Alessandra Nori, Mirella Memmi, Dmitry Terentyev, Federica Turcato, Giorgia Valle, Nicoletta Rizzi, Carlo Napolitano, Sandor Gyorke,[...]. Circulation 2006
149
14


TECRL, a new life-threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT.
Harsha D Devalla, Roselle Gélinas, Elhadi H Aburawi, Abdelaziz Beqqali, Philippe Goyette, Christian Freund, Marie-A Chaix, Rafik Tadros, Hui Jiang, Antony Le Béchec,[...]. EMBO Mol Med 2016
46
30

Prevalence of the congenital long-QT syndrome.
Peter J Schwartz, Marco Stramba-Badiale, Lia Crotti, Matteo Pedrazzini, Alessandra Besana, Giuliano Bosi, Fulvio Gabbarini, Karine Goulene, Roberto Insolia, Savina Mannarino,[...]. Circulation 2009
530
13


FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death.
Xander H T Wehrens, Stephan E Lehnart, Fannie Huang, John A Vest, Steven R Reiken, Peter J Mohler, Jie Sun, Silvia Guatimosim, Long Sheng Song, Nora Rosemblit,[...]. Cell 2003
527
13

A cardiac arrhythmia syndrome caused by loss of ankyrin-B function.
Peter J Mohler, Igor Splawski, Carlo Napolitano, Georgia Bottelli, Leah Sharpe, Katherine Timothy, Silvia G Priori, Mark T Keating, Vann Bennett. Proc Natl Acad Sci U S A 2004
233
13

Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of β-blockade.
Gareth J Padfield, Leenah AlAhmari, Krystien V V Lieve, Tasneem AlAhmari, Thomas M Roston, Arthur A Wilde, Andrew D Krahn, Shubhayan Sanatani. Heart Rhythm 2016
29
44


Inherited calcium channelopathies in the pathophysiology of arrhythmias.
Luigi Venetucci, Marco Denegri, Carlo Napolitano, Silvia G Priori. Nat Rev Cardiol 2012
120
12

Risk stratification in the long-QT syndrome.
Silvia G Priori, Peter J Schwartz, Carlo Napolitano, Raffaella Bloise, Elena Ronchetti, Massimiliano Grillo, Alessandro Vicentini, Carla Spazzolini, Janni Nastoli, Georgia Bottelli,[...]. N Engl J Med 2003
903
12

CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia.
E Di Pasquale, F Lodola, M Miragoli, M Denegri, J E Avelino-Cruz, M Buonocore, H Nakahama, P Portararo, R Bloise, C Napolitano,[...]. Cell Death Dis 2013
78
15

Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21.
H Lahat, M Eldar, E Levy-Nissenbaum, T Bahan, E Friedman, A Khoury, A Lorber, D L Kastner, B Goldman, E Pras. Circulation 2001
179
12

Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death.
Dmitry Terentyev, Alessandra Nori, Massimo Santoro, Serge Viatchenko-Karpinski, Zuzana Kubalova, Inna Gyorke, Radmila Terentyeva, Srikanth Vedamoorthyrao, Nico A Blom, Giorgia Valle,[...]. Circ Res 2006
146
12

Structure of the rabbit ryanodine receptor RyR1 at near-atomic resolution.
Zhen Yan, Xiaochen Bai, Chuangye Yan, Jianping Wu, Zhangqiang Li, Tian Xie, Wei Peng, Changcheng Yin, Xueming Li, Sjors H W Scheres,[...]. Nature 2015
281
12

Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
Ferran Roses-Noguer, Julian W E Jarman, Jonathan R Clague, Jan Till. Heart Rhythm 2014
60
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.